Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Compugen Ltd CGEN

Healthcare Biotechnology
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company... see more

Recent & Breaking News (NDAQ:CGEN)

Compugen to Disclose Novel Cancer Immunotherapy Target Candidate and Comprehensive Target Characterization Infrastructure at Today's Analyst and Investor Day

Business Wire June 8, 2015

Compugen to Present at Jefferies 2015 Global Healthcare Conference in New York

Business Wire May 28, 2015

Compugen to Hold Analyst and Investor Day in New York

Business Wire May 27, 2015

Compugen Ltd. Reports First Quarter 2015 Results

Business Wire May 5, 2015

Compugen First Quarter 2015 Conference Call Scheduled for Tuesday, May 5, 2015 at 10:00 AM ET

Business Wire April 28, 2015

Compugen Obtains Rights to Use Biological Systems and Materials from the US National Institutes of Health

Business Wire April 14, 2015

Compugen to Present at Two Immuno-Oncology Conferences in April

Business Wire April 6, 2015

Compugen Announces Planned Relocation of Headquarters to Larger Facilities

Business Wire March 19, 2015

Compugen to Present at Two Oncology Conferences in March

Business Wire March 2, 2015

Compugen Expands and Strengthens Business Development Team

Business Wire February 23, 2015

Compugen Ltd. Reports Fourth Quarter and Calendar 2014 Results

Business Wire February 10, 2015

Compugen Presents New Results Supporting CGEN-15049 as Potential Cancer Immunotherapy Target

Business Wire February 9, 2015

Compugen Fourth Quarter and Year-End 2014 Conference Call Scheduled for Tuesday, February 10, 2015 at 10:00 AM EST

Business Wire February 3, 2015

Compugen to Present Cancer Immunotherapy Targets at Two Tumor Immunology Conferences This Month

Business Wire February 2, 2015

Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets

Business Wire January 5, 2015

Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University

Business Wire December 18, 2014

Compugen to Present at Oppenheimer 25th Annual Healthcare Conference

Business Wire December 3, 2014

Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of Cancer-Related Immune Checkpoints

Business Wire December 2, 2014

Compugen to Present at Jefferies 2014 Global Healthcare Conference in London

Business Wire November 12, 2014

Compugen Ltd. Reports Third Quarter 2014 Financial Results

Business Wire October 29, 2014